Author: Ravi Shankar

IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) — SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in October 2026. SBC Medical will conduct presentations and one-on-one meetings with institutional investors.

Below is a summary of the Company’s scheduled participation in upcoming investor conferences:

Noble Capital Markets October 2026 Emerging Growth Virtual Equity Conference
Date: October 1-2, 2026
Format: Virtual
Registration: Link

Maxim Growth Summit 2026
Date: October 14, 2026
Format: In-person (New York)
Registration: Link

The ThinkEquity Conference 2026
Date: October 15, 2026
Format: In-person (New York)
Registration: Link

About SBC Medical Group Holdings Incorporated

SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, Hair Loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000^® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com

For more insights and updates from SBC Medical, follow us on LinkedIn

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

Contacts

Hikaru Fukui
Head of IR Department
E-mail: ir@sbc-holdings.com

Kodiak on target to complete its safety case validation and begin unsupervised driverless highway service by year end

Under Kodiak’s driverless launch program, the company is conducting daily preparation runs along Interstate 45, as well as driverless validation testing at closed-course test tracks

MOUNTAIN VIEW, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) — Kodiak AI, Inc. (“Kodiak”) (Nasdaq: KDK), a leading provider of Physical AI-powered autonomous driving technology, today announced its plans to launch unsupervised long-haul driverless service on the Dallas-Houston freight lane by the end of 2026.

Kodiak began its driverless long-haul launch program in August on its driverless-ready software and hardware platform, and now consistently completes deliveries between its Lancaster, Texas, hub and its launch destination in Houston without human intervention. During these end-to-end deliveries, the safety observer never touched the wheel, including on surface streets.

A video of a complete, end-to-end delivery is available here.

The company’s driverless launch program is designed to complete the final testing and validation necessary for Kodiak’s initial long-haul safety case. Kodiak has operated daily test drives since August on its launch platform and conducted driverless testing at closed-course test tracks. These drives are part of Kodiak’s final validation process before commencing driver-out operations.

Kodiak’s growing record of intervention-free deliveries on its launch lane demonstrates its driverless readiness.

“Our progress since beginning our final push towards driverless commercial deliveries has been incredible, and it is a strong signal we are ready to scale unsupervised driverless service on long-haul lanes,” said Don Burnette, Founder and Chief Executive Officer of Kodiak. “We have almost two years experience in driverless operations – no human in the cab – for a paying customer in the Permian Basin. Our final driverless launch initiative has readied the same Kodiak Driver for highways, and the results are exactly what we anticipated. We are on track to complete our preparations and launch driverless highway service by the end of this year.”

As of the end of August, Kodiak’s Autonomy Readiness Measure (ARM) for the long-haul domain stood at 93%. The ARM measures the percentage of claims and evidence in Kodiak’s safety case for driverless operations that are materially complete. Kodiak’s safety case is a structured argument, supported by evidence, that the Kodiak Driver, the company’s autonomous driving system, can operate safely in a defined operating environment. The company expects to reach 100% and launch driverless operations by year end.

Dallas to Houston: Kodiak’s first driverless lane

Kodiak’s first driverless long-haul lane will connect the Dallas–Fort Worth and Houston metropolitan areas, 219 miles apart along Interstate 45. The DFW to Houston route represents one of the densest freight lanes in the United States. Kodiak has delivered freight on the Dallas to Houston route since 2019 with safety drivers in the cab. Over that time, the company has driven more than 3.5 million autonomous miles.

Preparing for launch at the test track

Concurrently, Kodiak is conducting driverless tests at closed-course test tracks, where it is deliberately stress-testing the Kodiak Driver under real-world conditions that occur too rarely, or are too risky, to test on public highways. Together, the programs give Kodiak the testing and validation required to close its safety case in advance of driverless highway launch.

Permian provides a proven driverless foundation

Kodiak’s long-haul driverless launch builds on the company’s nearly two years of commercial driverless operations in the industrial sector. In December 2024, Kodiak became the first company to deploy driverless technology in customer owned-and-operated trucks, when the company began hauling freight with no one in the cab with Atlas Energy Solutions in the Permian Basin of West Texas and Eastern New Mexico.

As of June 30, 2026, the Kodiak Driver had been integrated into 35 driverless trucks owned and operated by Atlas and surpassed 40,000 cumulative hours of paid driverless operations.

Forward Looking Statements

This press release includes forward-looking statements including regarding Kodiak’s or its management teams’ expectations, hopes, beliefs, intentions or strategies regarding the future. Forward-looking statements may be identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “forecast,” “intend,” “expect,” “may,” “plan,” “potential,” “project,” “seek,” “should,” “will,” “would” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding: expectations regarding the benefits and performance of Kodiak’s technology; Kodiak’s expectations with respect to closing its long-haul safety case and launching driverless operations on public highways in Texas by the end of 2026; and Kodiak’s expectations with respect to its future performance and success. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Kodiak’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied upon by any investors as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Kodiak. These forward-looking statements are subject to a number of risks and uncertainties, including changes in business, market, financial, political and legal conditions; the rapid evolution of autonomous vehicle technology and flaws or errors in Kodiak’s solutions or flaws in or misuse of autonomous vehicle technology in general; risks related to the rollout of Kodiak’s business and the timing of expected business milestones; the effects of competition on Kodiak’s business; supply shortages in the materials necessary for the production of the Kodiak Driver; risks related to working with third-party manufacturers for key components of the Kodiak Driver; risks related to the retrofitting of Kodiak’s vehicles by third parties; the termination or suspension of any of Kodiak’s contracts or the reduction in counterparty spending; delays in Kodiak’s operational roadmap with key partners and customers; and Kodiak’s ability to raise capital in the near term and long term. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Kodiak with the Securities and Exchange Commission, including under the heading “Risk Factors.” If any of these risks materialize or any assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Kodiak does not presently know, or that Kodiak currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.

In addition, forward-looking statements reflect Kodiak’s expectations, plans or forecasts of future events and views as of the date they are made. Kodiak anticipates that subsequent events and developments will cause Kodiak’s assessments to change. However, while Kodiak may elect to update these forward-looking statements at some point in the future, Kodiak specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Kodiak’s assessments as of any date subsequent to the date they are made.

About Kodiak AI, Inc.
Kodiak AI, Inc. (Nasdaq: KDK) is a leader in Physical AI, developing driverless technology that powers machines that move. The core of the company’s solution is the Kodiak Driver, a vehicle-agnostic autonomous driving system that combines advanced AI-powered software with modular hardware. Today, the Kodiak Driver operates in the long-haul trucking, industrial trucking, and defense sectors, and is already deployed in commercial operation with no one in the cab. Kodiak AI commercializes its technology through both a Driver-as-a-Service business model and strategic partnerships. In 2024, Kodiak achieved a historic milestone, becoming the first company to deploy driverless technology in customer-owned driverless semi-trucks. Commercial partners and customers include Atlas Energy Solutions, IKEA, Bridgestone, Werner Enterprises, C.R. England, General Dynamics Land Systems, and Roehl Transport.

For more information about Kodiak, please visit https://kodiak.ai/investors. Kodiak’s press kit with videos and images can be found HERE.

Kodiak Media Contacts
Pete Bigelow
Public Relations Manager, Kodiak AI
+1 303-443-4441
pete.bigelow@kodiak.ai

Kylee Keskerian
PR Consultant for Kodiak AI
+1 419-822-6417
kylee@futuristacommunications.com

A video accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/5f1d23d9-a29f-4aed-9214-a950caaf8660

NEW YORK and LONDON and LEAMINGTON, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, hospitality and wellness industries, today announced that the Company will release its financial results for the first fiscal quarter ended August 31, 2026, before the financial markets open on Thursday, October 8, 2026.

Live Conference Call and Audio Webcast

Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Tilray’s Investor Relations website.

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

Contacts:

Tilray Brands Media: news@tilray.com

Investors: investors@tilray.com

SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.

Company Webcast

The webcast presentation will take place at 11:30 a.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/Yy1V3pgKbZQ. The webcast will also be available for replay following the event.

1×1 Meetings

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/fall2026invreg/. 

About INVO Fertility

We are a healthcare services fertility company dedicated to expanding access to assisted reproductive technology (“ART”) care to patients in need. Our principal commercial strategy is focused on building, acquiring, and operating fertility clinics and related businesses and technologies. Our acquisition strategy focuses on U.S.-based, profitable fertility clinics. Our clinics offer a variety of fertility services including in vitro fertilization (“IVF”) and the intravaginal culture (“IVC”) procedure enabled by INVOcell. We have four operational fertility clinics in the United States. We also continue to engage in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman’s body. For more information, please visit invofertility.com.

For more information, please contact:

INVO Fertility, Inc.
Steve Shum, CEO
978-878-9505
sshum@invofertility.com

Investor Contact
Lytham Partners, LLC
Robert Blum
602-889-9700
INVO@lythampartners.com

GREENWOOD VILLAGE, Colo., Sept. 25, 2026 (GLOBE NEWSWIRE) — Umbra Companies Inc. (“Umbra” or the “Company”) (OTC: UCIX) today announced its intention to transition to fully reporting status and to file a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”). The Company currently expects to file the S-1 in early October 2026.

Benefits to Shareholders of Going Fully Reporting

Umbra believes becoming fully reporting with the SEC can create meaningful, long-term value for shareholders by strengthening transparency, improving disclosure consistency, and enhancing overall investor confidence. Key shareholder benefits include:

Greater Transparency and Visibility

• Investors gain access to SEC-standard disclosures that are more consistent and easier to track over time.

Improved Disclosure Quality and Consistency

• SEC reporting provides a structured cadence and established reporting expectations, supporting clearer and more reliable communication.

Enhanced Credibility with Investors and Market Participants

• SEC filings serve as a recognized benchmark for public-company disclosure and can reinforce confidence in the Company’s commitment to accountability.

Better Comparability for Shareholders

• SEC reporting helps investors evaluate Umbra using familiar reporting formats and timelines.

Potential to Broaden Investor Access

• Many investors and platforms prioritize SEC-reporting companies, which may improve liquidity and access over time.

Building on a Strong Record of Quarterly Financial Updates

Umbra notes that it has been providing quarterly financial information to investors for the past five years. The Company’s move toward SEC fully reporting is intended to build on that track record by transitioning from periodic updates to an ongoing SEC reporting framework with standardized disclosure.

“Our priority has always been delivering clear financial visibility to shareholders,” said Rohn Monroe, CEO of Umbra Companies Inc. “Moving toward full SEC reporting and filing an S-1 in early October 2026 is designed to strengthen transparency, improve consistency, and support long-term shareholder value.”

About Umbra Companies Inc.

Umbra Companies Inc. is a public company traded on the OTC Markets under the ticker symbol UCIX. Investor information is available at umbracompaniesinc.com.

Forward-Looking Statements

This press release includes forward-looking statements, including statements regarding the Company’s intention to become fully reporting and to file an S-1 with the SEC, and the Company’s expected timing. These statements involve risks and uncertainties, including the SEC’s review process and whether any such registration statement is declared effective. The Company undertakes no obligation to update these forward-looking statements except as required by law.

CONTACT: Contact
Umbra Companies Inc.
6312 S. Fiddlers Circle Suite 300E 
Greenwood Village, CO 80111
O: +1.833.833.2913
Pr@umbraucix.com  
Website: umbracompaniesinc.com

WISeKey Announces Results of Class B Share Election and Name Change of BVI Merger Subsidiary to WISeQey Corp.

Zug, Switzerland, September 25, 2026 – WISeKey International Holding Ltd (“WISeKey” or the “Company”) (SIX: WIHN; NASDAQ: WKEY) today announced the results of the share election process conducted in connection with the previously announced proposed cross-border merger of WISeKey with and into its British Virgin Islands subsidiary, formerly known as WISeKey International Corp. (the “Merger”).

The Company also announced that WISeKey International Corp. has changed its name to WISeQey Corp. (“WISeQey”), effective September 16, 2026. WISeQey will be the surviving company in the Merger.

Results of the Class B Share Election
The election period for holders of WISeKey Class B registered shares concluded on September 23, 2026 at 14:00 CEST. Under the terms of the Merger, eligible holders were entitled to elect, on a share-by-share basis, to receive either:

• one WISeQey ordinary share for each WISeKey Class B share held; or
• ten WISeQey Class B shares for each WISeKey Class B share held, subject to the applicable Class B share cap and related allocation mechanics.

Holders who did not make a timely and valid election will receive one WISeQey ordinary share for each WISeKey Class B share held in accordance with the terms of the Merger.

Based on the final election results, holders of 518 WISeKey Class B shares validly elected to receive WISeQey Class B shares. Accordingly, upon completion of the Merger, WISeQey expects to issue:

• 5,180 WISeQey Class B shares in respect of valid elections made by holders of WISeKey Class B shares;
• 4,176,654 WISeQey ordinary shares in respect of the remaining WISeKey Class B shares, including WISeKey Class B shares represented by ADSs; and
• 1,819,060 WISeQey Class F shares in exchange for the outstanding WISeKey Class A shares.

Next Steps in the Redomiciliation
The proposed Merger was approved by WISeKey shareholders at the Extraordinary General Meeting held on September 9, 2026. The completion of the Merger remains subject to the satisfaction of the remaining closing conditions and completion of the applicable Swiss and BVI corporate, regulatory and administrative procedures.

The Company will provide a further update regarding the effective date of the Merger and the commencement of trading of WISeQey ordinary shares on Nasdaq and SIX Swiss Exchange once the remaining conditions and implementation steps have been completed.

About WISeKey
WISeKey International Holding Ltd (“WISeKey”, SIX: WIHN; Nasdaq: WKEY) is a global leader in cybersecurity, digital identity, and IoT solutions platform. It operates as a Swiss-based holding company through several operational subsidiaries, each dedicated to specific aspects of its technology portfolio. The subsidiaries include (i) SEALSQ Corp (Nasdaq: LAES), which focuses on semiconductors, PKI, and post-quantum technology products, (ii) WISeID, which specializes in RoT and PKI solutions for secure authentication and identification in IoT, blockchain, and AI, (iii) WISeSat AG, which focuses on space technology for secure satellite communication, specifically for IoT applications, (iv) WISe.ART Corp, which focuses on trusted blockchain NFTs and operates the WISe.ART marketplace for secure NFT transactions, and (v) SEALCOIN AG, which focuses on decentralized physical internet with DePIN technology and houses the development of the SEALCOIN platform.

Each subsidiary contributes to WISeKey’s mission of securing the internet while focusing on its respective areas of research and expertise. Their technologies seamlessly integrate into the comprehensive WISeKey platform. WISeKey secures digital identity ecosystems for individuals and objects using blockchain, AI, and IoT technologies. With over 1.6 billion microchips deployed across various IoT sectors, WISeKey plays a vital role in securing the Internet of Everything. Trusted by the OISTE/WISeKey cryptographic Root of Trust, WISeKey provides secure authentication and identification for IoT, blockchain, and AI applications. The WISeKey Root of Trust ensures the integrity of online transactions between objects and people. For more information on WISeKey’s strategic direction and its subsidiary companies, please visit www.wisekey.com.

Press and investor contacts:

WISeKey International Holding Ltd  Company Contact:  Carlos Moreira Chairman & CEO Tel: +41 22 594 30 00 info@wisekey.com

WISeKey Investor Relations (US)  Contact:  Lena Cati The Equity Group Inc. Tel: +1 212 836-9611 lena.cati@theequitygroup.com

Disclaimer:
This communication expressly or implicitly contains certain forward-looking statements concerning WISeKey International Holding Ltd and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of WISeKey International Holding Ltd to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. WISeKey International Holding Ltd is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

This press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, and it does not constitute an offering prospectus within the meaning of the Swiss Financial Services Act (“FinSA”) or advertising within the meaning of the FinSA. Investors must rely on their own evaluation of WISeKey and its securities, including the merits and risks involved. Nothing contained herein is, or shall be relied on as, a promise or representation as to the future performance of WISeKey.

Important Additional Information and Where to Find It
In connection with the merger, WISeQey filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form F-4 (File No. 333-297507), which was declared effective on July 31, 2026 and includes a prospectus of WISeQey. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY, BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE MERGER. The registration statement, prospectus, and other documents filed by WISeKey or WISeQey with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov or by directing a request to WISeKey International Holding Ltd, General-Guisan-Strasse 6, 6300 Zug, Switzerland.

Participants in the Solicitation
WISeKey, WISeQey, and their respective directors and executive officers may be deemed to have been participants in the solicitation of proxies from WISeKey’s shareholders in connection with the merger. Information regarding the interests of these directors and executive officers in the merger is included in the prospectus. Additional information regarding WISeKey’s directors and executive officers is also included in WISeKey’s Annual Report on Form 20-F for the fiscal year ended December 31, 2025, filed with the SEC. These documents are available free of charge at the SEC’s website at www.sec.gov.

No Offer or Solicitation
This communication is for informational purposes only and is not intended to and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.

Cautionary Statement Regarding Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are typically identified by words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “should,” “would,” “could,” “may,” and similar expressions. These forward-looking statements include, but are not limited to, statements regarding: the anticipated benefits of the redomiciliation and merger; the expected timing and completion of the merger and the effectiveness thereof; the satisfaction of remaining conditions to the merger, including regulatory approvals; the expected listing of WISeQey shares on Nasdaq and SIX Swiss Exchange; and the expected number and type of shares to be issued in connection with the merger.

These forward-looking statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which WISeKey and WISeQey operate, and management’s beliefs and assumptions. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Important factors that could cause actual results to differ materially from forward-looking statements include, but are not limited to: the risk that the merger may not be completed in a timely manner or at all; failure to satisfy remaining closing conditions; failure to obtain required regulatory approvals, including from Nasdaq, SIX Swiss Exchange, or the Swiss Takeover Board; the risk that the anticipated benefits of the redomiciliation may not be realized; changes in applicable laws or regulations; general economic and market conditions; and other risks and uncertainties described in WISeKey’s filings with the SEC, including its Annual Report on Form 20-F. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this communication. WISeKey does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Transaction in Own Shares

September 24, 2026

• • • • • • • • • • • • • • • •

Shell plc (the ‘Company’) announces that on 24 September 2026 it purchased the following number of Shares for cancellation.

Aggregated information on Shares purchased according to trading venue:

Date of Purchase	Number of Shares purchased	Highest price paid	Lowest price paid	Volume weighted average price paid per share	Venue	Currency
24/09/2026	495,544	£ 36.5050	£ 36.0600	£ 36.2972	LSE	GBP
24/09/2026	–	–	–	–	Chi-X (CXE)	GBP
24/09/2026	–	–	–	–	BATS (BXE)	GBP
24/09/2026	276,732	€ 42.5150	€ 41.9850	€ 42.2615	XAMS	EUR
24/09/2026	–	–	–	–	CBOE DXE	EUR
24/09/2026	–	–	–	–	TQEX	EUR

These share purchases form part of the on- and off-market limbs of the Company’s existing share buy-back programme previously announced on 30 July 2026.

In respect of this programme, Goldman Sachs International will make trading decisions in relation to the securities independently of the Company for a period from 30 July 2026 up to and including 23 October 2026.

The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020)  through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.

In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Goldman Sachs International on behalf of the Company as a part of the buy-back programme is detailed below.

Enquiries:

Media International: +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html

Attachment

• 20260924_Shell RNS – full version

Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026

NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer and Secretary, has informed the company of his decision to resign, effective November 1, 2026. Jonathan Dorfman, Teladoc Health’s current Senior Vice President, Securities and Corporate Law, will succeed Vandervoort and be promoted to Chief Legal Officer and Secretary effective November 2, 2026.

Since joining Teladoc Health in 2015, Vandervoort has helped guide the company through its initial public offering, the rapid acceleration of virtual care adoption during the pandemic and an evolving regulatory landscape.

“For more than a decade, Adam has been a trusted partner to Teladoc Health’s leadership team, helping advance our mission and increase our impact,” said Chuck Divita, Chief Executive Officer of Teladoc Health. “His leadership has strengthened our company and helped establish a foundation for the broader virtual care industry. We are grateful for Adam’s many contributions and for his support through this transition.”

Dorfman joined Teladoc Health in 2020 through the acquisition of Livongo, where he led SEC compliance and corporate governance. He has served in legal roles of increasing responsibility at Teladoc Health, most recently leading the company’s SEC reporting and disclosure, corporate governance, capital markets and mergers and acquisitions. Previously, Dorfman was an in-house lawyer at USG Corporation and practiced law at Sidley Austin LLP.

“Jonathan is a proven leader who has earned the trust of our Board and leadership team,” Divita said. “His expertise, judgment and deep understanding of our business make him the natural choice to succeed Adam, and his promotion reflects the strength of the team Adam built.”

“I am honored to take on this role and grateful to Adam for the strong foundation he has built,” said Dorfman. “I look forward to working with our talented colleagues to support Teladoc Health’s mission and the people we serve.”

Dorfman holds a Juris Doctor from Northwestern University Pritzker School of Law and a Bachelor of Business Administration from the University of Michigan’s Stephen M. Ross School of Business.

About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Investors:
Michael Minchak
617-444-9612
ir@teladochealth.com

Media:
Lou Serio
202-569-9715
pr@teladochealth.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ec9b963d-f7ec-44a2-8a51-558b03c75218

GEL brings established relationships across Canada’s mining, utility and industrial sectors

BOCA RATON, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) — NOMAD Power Solutions, Inc. (“NOMAD” or the “Company”) (Nasdaq: NMAD) (formerly LIXTE Biotechnology Holdings), a provider of transportable, utility-grade battery energy storage systems through its wholly owned subsidiary, NOMAD Transportable Power Systems, today announced the appointment of Global Environmental Liquid Ltd. (“GEL”) as its sales representative in Canada.

Under the agreement, GEL will identify and develop opportunities for NOMAD’s transportable battery energy storage systems among Canadian utilities, mining and resource companies, and other industrial customers. GEL brings established relationships across many of the markets NOMAD targets, particularly in remote and northern communities and in industrial, energy, and infrastructure applications.

The appointment expands NOMAD’s commercial reach in Canada, where mining, remote-site operations, utilities, and other industrial customers present opportunities for flexible, rapidly deployable power. NOMAD’s utility-scale, semi-trailer-mounted battery systems can be deployed in under one hour, delivering megawatt-scale energy storage without the lead times and infrastructure commitments of permanent installations.

Earlier this month, NOMAD showcased its technology to the Canadian mining and exploration community at the CEN-CAN Mining Expo in Thunder Bay, Ontario. The Company displayed a transportable battery energy storage unit and met with prospective customers across the mining, exploration, and natural resource sectors. GEL will build on that outreach as NOMAD expands its commercial efforts across Canada.

“Canada’s mining and resource sectors are well suited to NOMAD’s technology, particularly in remote locations where customers need flexible, rapidly deployable power,” said Jim Allan, Director of Sales at NOMAD Transportable Power Systems. “GEL brings established relationships across several of our priority markets, providing us with an experienced local representative as we expand our commercial presence in Canada.”

NOMAD has already established an operating presence in Canada. The Company’s 1 MW / 2 MWh Traveler transportable battery energy storage system achieved UL 9540 certification after a field deployment with Missanabie Cree First Nation in Northern Ontario, where the system continues to support emergency preparedness and reduce reliance on diesel generation.

“We consistently hear from operators about the challenge of securing reliable power before permanent infrastructure is in place,” said Peter Strang, Chairman and Chief Strategy Officer of Global Environmental Liquid Ltd. “NOMAD’s transportable battery systems offer a compelling solution to this challenge, and we look forward to introducing the technology to customers across our Canadian network.”

NOMAD and GEL also plan to participate in the PDAC 2027 Convention, to be held March 7–10, 2027, in Toronto, as well as in additional industry conferences and events across Canada.

About NOMAD Power Solutions, Inc.

NOMAD Power Solutions, Inc., through its wholly owned subsidiary NOMAD Transportable Power Systems, provides transportable, utility-grade battery energy storage systems. The company’s mobile battery energy storage system (BESS) platforms deliver rapidly deployable, scalable energy solutions for electric utilities, data centers, commercial and industrial customers, emergency response, renewable energy integration, and grid modernization. By mobilizing energy storage, NOMAD enables customers to deploy power where and when it is needed without waiting for permanent infrastructure.

For more information, please visit https://ir.nomadpower.com/.

About Global Environmental Liquid Ltd.

Global Environmental Liquid Ltd., operating as GEL Worldwide (“GEL”), is a privately owned environmental utility platform delivering decentralized water and wastewater infrastructure across Ontario, including through its GEL North division serving northern and remote communities. GEL manages the full infrastructure lifecycle — site development, system deployment, and long-term operations — for First Nations and Indigenous communities, remote and northern communities, residential and mixed-use developments, municipalities, and industrial, oil, gas, and energy operations, with proprietary treatment technologies delivered through a partnership with Miranda Water Technologies. For more information, visit geliquid.com.

# # #

Investor and Media Contact:

PondelWilkinson pwinvestor@pondel.com

Todd Kehrli: (310) 279-5961; tkehrli@pondel.com
Michael Wichman: (917) 526-0855; mwichman@pondel.com

NEW HAVEN, CT and PRINCETON, NJ, Sept. 25, 2026 (GLOBE NEWSWIRE) — Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences company focused on addressing unmet medical needs and providing high-quality genomic and biomarker testing solutions, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.

Company Webcast

The webcast presentation will take place at 12:00 p.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/KagLPZ5we82. The webcast will also be available for replay following the event.

1×1 Meetings

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/fall2026invreg/.      

About Niki BioSolutions

Niki BioSolutions is a clinical-stage life sciences company focused on unmet medical needs and high-quality genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations through its CLIA-certified, CAP-accredited laboratory. The company combines proprietary technologies with a commitment to scientific rigor to support precision medicine across a range of therapeutic areas, including neurodegeneration and other brain health conditions. Niki BioSolutions collaborates with leading academic centers, disease foundations, and biopharma companies.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often use words such as “believe,” “may,” “will,” “estimate,” “target,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “propose,” “plan,” “project,” “forecast,” “predict,” “potential,” “seek,” “future,” “outlook,” and similar variations and expressions. Forward-looking statements are those that do not relate strictly to historical or current facts. Examples of forward-looking statements may include, among others, Niki BioSolutions’ ability to successfully operate its business and provide value to stockholders; Niki BioSolutions’ future financial, business and operating performance and goals; annualized recurring revenue and customer retention; ongoing or future ability to maintain or improve its financial position, cash flows, and liquidity and its expected financial needs; potential financing and ability to obtain financing; acquisition strategy and proposed acquisitions and, if completed, their potential success and financial contributions; strategy and strategic goals, including being able to capitalize on opportunities; expectations relating to Niki BioSolutions and its industry, outlook and market trends; total addressable market and serviceable addressable market and related projections; plans, strategies and expectations for increasing revenue and executing growth initiatives. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity and development of the industries in which Niki BioSolutions operates may differ materially from those made in or suggested by the forward-looking statements. Therefore, investors should not rely on any of these forward-looking statements. Factors that may cause actual results to differ materially include changes in the markets in which Niki BioSolutions operates, the financial markets, economic, business and regulatory factors, and other factors, such as Niki BioSolutions’ ability to execute on its strategies. More detailed information about risk factors can be found in the registration statement on Form S-4 filed with the Securities and Exchange Commission (the “SEC”) on October 6, 2025 (File No. 333-290742), and in other reports filed under the company’s prior name, Aptorum Group Limited, and that will be filed by Niki BioSolutions with the SEC. Niki BioSolutions does not undertake any duty to update forward-looking statements after the date of this press release.

Investor Contact:

Lytham Partners, LLC
Ben Shamsian
646-829-9701
shamsian@lythampartners.com